Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BNG-1 in Ischemic Stroke Recovery
NCT01675115Phase 3Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Aug 2012
- Primary completion
- Nov 2014
- Modality
- Botanical
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of BNG-1 Powder in ischemic stroke (2 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoint: Favorable Rate (Alive, MRS < 3, BI >= 60) at 12 weeks. Started Aug 2012; status: completed.
02
Drugs
BNG-1 Powder
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01675115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01675115.